Fundraising Fox
BEVC
Venture capitalSan Francisco · Pre-Seed–Series A · 18 people tracked
Find your way into BEVC
Sign up to see every warm intro you have to BEVC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BEVC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
BEVC backs founders transforming frontier science into disruptive companies, investing at the intersection of science, computation, and engineering. It focuses on transformational technology with high impact potential across the frontiers of biology and health, AI and the future of intelligence, and deep tech spanning molecules, materials, and energy. The firm invests early with conviction, applies technical and market rigor, and provides deep technical, strategic, and operational support to help teams build scalable, defensible businesses. BEVC positions itself as the preferred investor for the UCSF and Berkeley ecosystems and Bakar-funded initiatives, contributing capital, domain expertise, and networks.
Source: firm website, verified Sep 26, 2026.
Team · 18 people
from the firm's website & curated & public directories
Founder mafia
2 people who came through BEVC went on to found or lead other companies.
What they invest in
from 8 of 8 portfolio companiesBiotech ×6AI & Machine Learning ×5Deep Tech ×4New Materials ×2Cleantech ×1Digital Health ×1Energy ×1FemTech ×1
HQs:United States×4Australia×1
Investments · 8 tracked
founders shown can be your intro pathBy year:2025 · 22023 · 13 dated
Addition Therapeutics is a biotechnology company developing therapeutics, led by a scientific and clinical team.
BiotechHealthtechSouth San Francisco, US
Kathleen Collins(Director)inLawrence Kong(Executive Officer)inRon Park(President & CEO)inFrancine Gregoire(Chief Scientific Officer)inPriya Parameswaran(Chief Business Officer)in
BoardJayson Punwani(Director)in
Co-investorsPivotal Life SciencesSR One Capital ManagementAbingworth
AIMATX operates an AI platform for materials discovery that predicts material properties and guides targeted experimentation to shorten research cycles.
AI & Machine LearningDeep TechNew Materials
Co-investorsBerkeley FrontierBow CapitalTyche Partners
Dextera Biosciences develops dexabodies, a therapeutic modality built from D-amino acids that resists degradation by natural enzymes while retaining antibody-like specificity in a compact format, and can be conjugated to payloads such as steroids or toxins for targeted delivery.
AI & Machine LearningBiotech
Dev Sidhu(SAB Chair & Co-founder)Gregory Went(CEO & Chairman)Kyle Landgraf(VP of Discovery Research)
Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.
AI & Machine LearningBiotechDeep TechChippendale, AU
Tim Craven(CEO)inToby Passioura(Founder)inGlen McIntyre(Founder)Timothy Craven(Founder)
BoardCOREY GOODMAN(Director)inMATT HERSHENSON(Director)in
Co-investorsCivilization Ventures Management, LlcMRL Ventures FundPlayground GlobalvenBio PartnersAxial VCvenBio Global Strategic
Khemia Metals develops earth-abundant alloys intended to replace critical metals in battery production, aiming to make batteries lighter, cheaper, and more sustainable.
CleantechEnergyNew MaterialsSan Carlos, US
Helen Bergstrom(Executive Officer, Director)Brian Hardin(Executive Officer, Director)
BoardJoshua James(Director)David Schroeder(Director)
Co-investorsBaruch Future VenturesDangerous Ventures
Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Kevan Shokat(Co-Scientific Founder & Chairman of the SAB)Thomas Südhof(Co-Scientific Founder & SAB Member)Seth Stratton(Director)Dirk Langdorf(Director)Nicholas Hertz(Executive Officer, Director)
Co-investorsDolby Family VenturesSV Health InvestorsTwo Bear CapitalDementia Discovery FundKdT Ventures
PinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.
BiotechDigital HealthFemTechIndianapolis, US
Richard T. Kloos(Chief Medical Officer)inTimothy McMeekan(Co-Founder, Chief Financial Officer, and Chief Business Officer)Giulia Kennedy(Founder)Isaac Ro(Director)inRisa Stack(Director)inEric Wang(Executive Officer)
Co-investorsBlue Venture FundsCatalio Capital Management, LPMountain Group CapitalSandbox Industries
Radar Therapeutics develops precision-expressed mRNA-based therapeutics using its RADAR platform, which reads a cell's RNA profile in real time to activate genetic payloads only in targeted cells and avoid effects in non-target cells.
AI & Machine LearningBiotechDeep Tech
Co-investorsNFXPioneerStartXThe 23 FundKdT Ventures
Portfolio news
latest coverage across their companiesAddition Therapeutics · finsmes.com · Dec 17, 2025
Frequently asked questions
- How many investments has BEVC made?
- BEVC has 8 tracked investments, including 2 dated in the last 24 months.
- What stage does BEVC invest at?
- BEVC invests at the Pre-Seed, Seed, Series A stages.
- What sectors does BEVC focus on?
- BEVC focuses on AI & Machine Learning, Biotech, Deep Tech, Energy, Healthtech, New Materials, Sector Agnostic.
- Where is BEVC located?
- BEVC is headquartered in San Francisco, US.
- Who does BEVC co-invest with?
- BEVC most often shares deals with Civilization Ventures Management, Llc, Playground Global, SR One Capital Management, among 21 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.